Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fish oil fat emulsion dose study in gastric cancer surgery
ChiCTR2200059244Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2022
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of omega-3-acid triglycerides in gastric cancer (GC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Complication rate of postoperative infection. Planned start May 2022; status: not yet recruiting.
02
Drugs
omega-3-acid triglycerides
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2200059244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059244.